NCT04063748

Brief Summary

It is believed that persons with hearing impairment benefit from auditory rehabilitation (AR), i.e. regular assessment and training of their listening skills. However, the efficacy of auditory rehabilitation has not been investigated before. In Leuven (Belgium) an e-health app has been developed that enables performance assessment, listening skills training, and counselling for persons with hearing impairment. Currently, an RCT is prepared to evaluate the different modules in persons with hearing impairment. The experimental group will receive auditory rehabilitation training modules, and a control group will either receive training tasks that are NOT believed to transfer to improved listening skills or will not receive any training (passive control).

  1. 1.Do participants improve on the trained tasks in the LUISTER AR scheme and does this improvement transfer to an improvement in speech perception in noise (primary outcome), executive functioning and/or quality of life (secondary outcomes)?
  2. 2.Does training with the LUISTER AR scheme provide more benefit on primary and secondary outcomes than a placebo program (active control group) or no training (passive control group)?
  3. 3.Can improvement in speech in noise perception, obtained with the LUISTER AR scheme, be consolidated until 6 months after training has stopped?
  4. 4.Are certain user-specific or training-specific aspects correlated to improvement on task-specific learning as well as near- and far transfer

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2019

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

August 10, 2019

Completed
11 days until next milestone

First Posted

Study publicly available on registry

August 21, 2019

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 28, 2022

Completed
1.7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2024

Completed
Last Updated

February 17, 2023

Status Verified

February 1, 2023

Enrollment Period

3.7 years

First QC Date

August 10, 2019

Last Update Submit

February 15, 2023

Conditions

Keywords

auditory rehabilitation

Outcome Measures

Primary Outcomes (1)

  • Speech in noise intelligibility

    LIST sentences presented in speech-weighted noise. Participants are required to repeat sentences in noise. The Leuven Intelligibility Sentences Test (LIST, (van Wieringen \& Wouters, 2008)) was specifically designed for speech perception in noise assessment in CI users. The test has a high test-retest reliability and a steep slope making it very sensitive to small improvements in performance. An improvement of 2dB results in a clinically relevant improvement in speech. discrimination in noise. Therefore, the primary endpoint to validate the LUISTER AR scheme will be an improvement of 2dB on speech discrimination in noise.

    Change at 16 wks compared to baseline

Secondary Outcomes (7)

  • Executive functioning inhibition

    16 weeks, + 6 months

  • Executive functioning: task switching

    16 weeks, + 6 months

  • Executive functioning updating

    16 weeks, + 6 months

  • Fluid intelligence

    0 weeks, for baseline

  • Self-reported measure

    0 and 16 weeks, + 6 months

  • +2 more secondary outcomes

Study Arms (3)

Experimental

EXPERIMENTAL

Participants are asked to train (at least) 5 times a week during 15 - 20 mins. The first 4 sessions are training sessions, the fifth session is an in-training test session (DTT and phoneme discrimination).

Behavioral: Audiological rehabilitation

Placebo

OTHER

CI-users: Participants are asked to train (at least) 5 times a week during 15 - 20 mins. The first 4 sessions are training sessions, and the fifth session is an in-training test session (DTT and phoneme discrimination).

Behavioral: Placebo Rehabilitation

Passive Control

PLACEBO COMPARATOR

HA users: Participants do not receive an intervention.

Behavioral: Passive Control

Interventions

Experimental: tablet-based take-home auditory-cognitive training, which consists of phoneme tasks, words in quiet and in different types of noise

Also known as: LUISTER
Experimental

CI-users: Placebo, tablet-based take-home psychophysical tasks, reading (non auditory)

Placebo
Passive ControlBEHAVIORAL

No intervention in the passive control group for HA-users.

Passive Control

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • hearing impaired
  • sufficient knowledge of the Dutch language

You may not qualify if:

  • cognitively impaired

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

KU Leuven, Experimental ORL, Dept Neurosciences

Leuven, Vlaams Brabant, 3001, Belgium

Location

Related Publications (2)

  • Magits S, Boon E, De Meyere L, Dierckx A, Vermaete E, Francart T, Verhaert N, Wouters J, van Wieringen A. Comparing the Outcomes of a Personalized Versus Nonpersonalized Home-Based Auditory Training Program for Cochlear Implant Users. Ear Hear. 2023 May-Jun 01;44(3):477-493. doi: 10.1097/AUD.0000000000001295. Epub 2022 Oct 29.

  • van Wieringen A, Wouters J. Lilliput: speech perception in speech-weighted noise and in quiet in young children. Int J Audiol. 2023 Aug;62(8):747-755. doi: 10.1080/14992027.2022.2086491. Epub 2022 Jun 22.

Study Officials

  • Astrid van Wieringen

    KU Leuven

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The participant does not know whether (s)he receives treatment or placebo. The investigator and the outcomes assessor are blind to this information too. The care provide (speech therapist) would know after communication with the participant. In case of the HA-study, participants either receive an intervention or do not receive an intervention. Therefore, they cannot be masked.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants are assigned to either the test or the placebo group.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

August 10, 2019

First Posted

August 21, 2019

Study Start

January 1, 2019

Primary Completion

August 28, 2022

Study Completion

April 30, 2024

Last Updated

February 17, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share

Locations